57 related articles for article (PubMed ID: 28413508)
1. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies.
Montellano FA; Rücker V; Ungethüm K; Penalba A; Hotter B; Giralt M; Wiedmann S; Mackenrodt D; Morbach C; Frantz S; Störk S; Whiteley WN; Kleinschnitz C; Meisel A; Montaner J; Haeusler KG; Heuschmann PU
Eur Stroke J; 2024 May; ():23969873241250272. PubMed ID: 38711254
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Length of Hospital Stay And In-Hospital Adverse Events in Patients With Acute Decompensated Heart Failure: In-hospital 24-Hour Blood Pressure Monitoring Data.
Candemir M; Kızıltunç E; Nurkoç SG; Cihan B; Şahinarslan A
Hellenic J Cardiol; 2024 Jun; ():. PubMed ID: 38925251
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin and Vasopressin Antagonists in Heart Failure.
Vishram-Nielsen JK; Gustafsson F
Handb Exp Pharmacol; 2017; 243():307-328. PubMed ID: 28432473
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.
Wang H; Anstrom K; Ilkayeva O; Muehlbauer MJ; Bain JR; McNulty S; Newgard CB; Kraus WE; Hernandez A; Felker GM; Redfield M; Shah SH
JAMA Cardiol; 2017 Aug; 2(8):896-901. PubMed ID: 28492915
[TBL] [Abstract][Full Text] [Related]
7. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR;
Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial.
Masiá M; Padilla S; Ortiz de la Tabla V; González M; Bas C; Gutiérrez F
PLoS One; 2017; 12(4):e0175634. PubMed ID: 28426811
[TBL] [Abstract][Full Text] [Related]
10. Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help?
Cepoi MR; Duca ST; Chetran A; Costache AD; Spiridon MR; Afrăsânie I; Leancă SA; Dmour BA; Matei IT; Miftode RS; Miftode L; Prepeliuc CS; Haba MȘC; Bădescu MC; Costache II
Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38255650
[TBL] [Abstract][Full Text] [Related]
11. Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice.
Wu P; Wang L; Su X; Wang B; Cheng Y
Mol Biol Rep; 2023 Apr; 50(4):3755-3765. PubMed ID: 36662451
[TBL] [Abstract][Full Text] [Related]
12. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.
Mu D; Cheng J; Qiu L; Cheng X
Front Cardiovasc Med; 2022; 9():901990. PubMed ID: 35859595
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarkers of Renal Dysfunction and Congestion in Heart Failure.
Zdanowicz A; Urban S; Ponikowska B; Iwanek G; Zymliński R; Ponikowski P; Biegus J
J Pers Med; 2022 May; 12(6):. PubMed ID: 35743683
[TBL] [Abstract][Full Text] [Related]
14. The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia.
Saadatifar H; Niayeshfar A; Mard-Soltani M; Bahrampour E; Khalili S; Alinezhad Dezfuli D; Pouriamehr S
Int J Cardiovasc Imaging; 2022 Apr; 38(4):833-840. PubMed ID: 34727252
[TBL] [Abstract][Full Text] [Related]
15. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
Düngen HD; Tscholl V; Obradovic D; Radenovic S; Matic D; Musial Bright L; Tahirovic E; Marx A; Inkrot S; Hashemi D; Veskovic J; Apostolovic S; von Haehling S; Doehner W; Cvetinovic N; Lainscak M; Pieske B; Edelmann F; Trippel T; Loncar G
ESC Heart Fail; 2018 Apr; 5(2):288-296. PubMed ID: 29476612
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial.
Jia J; Chang GL; Qin S; Chen J; He WY; Lu K; Li Y; Zhang DY
Exp Ther Med; 2017 Apr; 13(4):1554-1560. PubMed ID: 28413508
[TBL] [Abstract][Full Text] [Related]
17. Prognostic performance of copeptin among patients with acute decompensated heart failure.
Ozmen C; Deveci OS; Tepe O; Yesildas C; Ünal İ; Yıldız İ; Eker Akıllı R; Deniz A; Demir M; Kanadaşı M; Usal A
Acta Cardiol; 2021 Oct; 76(8):842-851. PubMed ID: 32666903
[TBL] [Abstract][Full Text] [Related]
18. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
19. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
